Federal Register of Legislation - Australian Government

Primary content

PB 2 of 2018 Determinations/Health as made
This instrument amends Schedule 1 to the National Health (Price and Special Patient Contribution) Determination 2010 (PB 109 of 2010).
Administered by: Health
Made 22 Jan 2018
Registered 24 Jan 2018
Tabled HR 05 Feb 2018
Tabled Senate 05 Feb 2018
Date of repeal 02 Feb 2018
Repealed by Division 1 of Part 3 of Chapter 3 of the Legislation Act 2003

 

PB 2 of 2018

National Health (Price and Special Patient Contribution) Amendment Determination 2018 (No. 1)

National Health Act 1953

I, LISA LA RANCE, Assistant Secretary, Pricing and PBS Policy Branch, Technology Assessment and Access Division, Department of Health, delegate of the Minister for Health, make this Determination under section 85B of the National Health Act 1953.

Dated                    22 January 2018

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

LISA LA RANCE

Assistant Secretary

Pricing and PBS Policy Branch

Technology Assessment and Access Division

Department of Health


 

1          Name of Instrument

            (1)        This Instrument is the National Health (Price and Special Patient Contribution) Amendment Determination 2018 (No. 1).

            (2)        This Instrument may also be cited as PB 2 of 2018.

2          Commencement

            This Instrument commences on 1 February 2018.

3          Amendment of the National Health (Price and Special Patient Contribution) Determination 2010 (PB 109 of 2010)

            Schedule 1 amends the National Health (Price and Special Patient Contribution) Determination 2010 (PB 109 of 2010).


Schedule 1     Amendments

[1]           Schedule 1, entry for Alendronic acid with colecalciferol in the form Tablet 70 mg (as alendronate sodium) with 70 micrograms colecalciferol

omit from the column headed “Claimed Price”:          8.47        substitute:             10.09

[2]           Schedule 1, entry for Alendronic acid with colecalciferol in the form Tablet 70 mg (as alendronate sodium) with 140 micrograms colecalciferol

omit from the column headed “Claimed Price”:          8.47        substitute:             10.09

[3]           Schedule 1, entry for Bisoprolol in the form Tablet containing bisoprolol fumarate 2.5 mg

omit from the column headed “Claimed Price”:          11.75     substitute:             12.51

[4]           Schedule 1, entry for Bisoprolol in the form Tablet containing bisoprolol fumarate 5 mg

omit from the column headed “Claimed Price”:          13.30     substitute:             14.07

[5]           Schedule 1, entry for Bisoprolol in the form Tablet containing bisoprolol fumarate 10 mg

omit from the column headed “Claimed Price”:          15.27     substitute:             16.03

[6]           Schedule 1, omit entry for Capecitabine

[7]           Schedule 1, entry for Captopril in the form Tablet 12.5 mg

omit from the column headed “Claimed Price”:          6.31        substitute:             6.79

[8]           Schedule 1, entry for Captopril in the form Tablet 25 mg [Brand: Zedace]

omit from the column headed “Claimed Price”:          7.70        substitute:             8.18

[9]           Schedule 1, entry for Captopril in the form Tablet 50 mg [Brand: Zedace]

omit from the column headed “Claimed Price”:          12.08     substitute:             12.56

[10]         Schedule 1, entry for Fluvoxamine in the form Tablet containing fluvoxamine maleate 50 mg

omit from the column headed “Claimed Price”:          8.13        substitute:             8.52

[11]         Schedule 1, entry for Fluvoxamine in the form Tablet containing fluvoxamine maleate 100 mg

omit from the column headed “Claimed Price”:          10.83     substitute:             11.23

[12]         Schedule 1, entry for Gliclazide

omit from the column headed “Claimed Price”:          11.34     substitute:             12.89

 

[13]         Schedule 1, entry for Indapamide in the form Tablet containing indapamide hemihydrate 1.5 mg (sustained release)

omit from the column headed “Claimed Price”:          11.77     substitute:             12.89

[14]         Schedule 1, entry for Indapamide in the form Tablet containing indapamide hemihydrate 2.5 mg

omit from the column headed “Claimed Price”:          9.51        substitute:             11.03

[15]         Schedule 1, entry for Lercanidipine in the form Tablet containing lercanidipine hydrochloride 10 mg

omit from the column headed “Claimed Price”:          4.52        substitute:             5.21

[16]         Schedule 1, entry for Lercanidipine in the form Tablet containing lercanidipine hydrochloride 20 mg

omit from the column headed “Claimed Price”:          5.82        substitute:             6.50

[17]         Schedule 1, entry for Levodopa with Carbidopa

omit from the column headed “Claimed Price”:          30.28     substitute:             31.12

[18]         Schedule 1, entry for Levonorgestrel with Ethinyloestradiol in the form Pack containing 21 tablets 150 micrograms-30 micrograms and 7 inert tablets

omit:

 

 

Oral

Microgynon 30 ED

4

5.68

14.07

[19]         Schedule 1, entry for Mirtazapine in the form Tablet 30 mg

omit from the column headed “Claimed Price”:          7.25        substitute:             8.00

[20]         Schedule 1, entry for Perindopril in the form Tablet containing perindopril arginine 2.5 mg

omit from the column headed “Claimed Price”:          6.04        substitute:             7.31

[21]         Schedule 1, entry for Perindopril in the form Tablet containing perindopril arginine 5 mg

omit from the column headed “Claimed Price”:          7.26        substitute:             8.25

[22]         Schedule 1, entry for Perindopril in the form Tablet containing perindopril arginine 10 mg

omit from the column headed “Claimed Price”:          8.68        substitute:             10.10

[23]         Schedule 1, entry for Perindopril with amlodipine in the form Tablet containing 5 mg perindopril arginine with 5 mg amlodipine
(as besylate)

omit from the column headed “Claimed Price”:          8.09        substitute:             9.18

[24]         Schedule 1, entry for Perindopril with amlodipine in the form Tablet containing 5 mg perindopril arginine with 10 mg amlodipine
(as besylate)

omit from the column headed “Claimed Price”:          8.73        substitute:             10.11

[25]         Schedule 1, entry for Perindopril with amlodipine in the form Tablet containing 10 mg perindopril arginine with 5 mg amlodipine
(as besylate)

omit from the column headed “Claimed Price”:          9.50        substitute:             11.03

[26]         Schedule 1, entry for Perindopril with amlodipine in the form Tablet containing 10 mg perindopril arginine with 10 mg amlodipine
(as besylate)

omit from the column headed “Claimed Price”:          10.15     substitute:             11.96

[27]         Schedule 1, entry for Perindopril with indapamide in the form Tablet containing perindopril arginine 2.5 mg with indapamide hemihydrate 0.625 mg

omit from the column headed “Claimed Price”:          6.44        substitute:             8.24

[28]         Schedule 1, entry for Perindopril with indapamide in the form Tablet containing perindopril arginine 5 mg with indapamide
hemihydrate 1.25 mg

omit from the column headed “Claimed Price”:          8.08        substitute:             9.18

[29]         Schedule 1, entry for Salbutamol in the form Nebuliser solution 2.5 mg (as sulfate) in 2.5 mL single dose units, 20

omit from the column headed “Claimed Price”:          2.80        substitute:             3.11

[30]         Schedule 1, entry for Salbutamol in the form Nebuliser solution 5 mg (as sulfate) in 2.5 mL single dose units, 20

omit from the column headed “Claimed Price”:          2.92        substitute:             3.23

[31]         Schedule 1, entry for Salbutamol in the form Pressurised inhalation 100 micrograms (as sulfate) per dose, 200 doses
(CFC-free formulation)

omit from the column headed “Claimed Price”:          4.63        substitute:             5.10